Polyethylene glycol–poly(ε-benzyloxycarbonyl-L-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma

Polyethylene glycol–poly(ε-benzyloxycarbonyl-L-lysine)-conjugated VEGF siRNA for antiangiogenic gene therapy in hepatocellular carcinoma

Gangmin Wang,1,* XiaoLong Gao,2,* GuoJun Gu,2 ZhiHong Shao,2 MingHua Li,2 PeiJun Wang,2 JianRong Yang,3 XiaoJun Cai,4 YongYong Li4 1Department of Urology, Huashan Hospital, Fudan University, 2Department of Radiology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 3Department of H...

Full description

Bibliographic Details
Main Authors: Wang GM, Gao XL, Gu GJ, Shao ZH, Li MH, Wang PJ, Yang JR, Cai XJ, Li YY
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:International Journal of Nanomedicine
Subjects:
PEG-SS-PLL
VEGF
HepG2
Hepatocellular carcinoma
siRNA.
Online Access:https://www.dovepress.com/polyethylene-glycol-polyepsilon-benzyloxycarbonyl-l-lysine-conjuga-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/polyethylene-glycol-polyepsilon-benzyloxycarbonyl-l-lysine-conjuga-peer-reviewed-article-IJN

Similar Items